PADI4 and peripheral arterial disease: Our study opens the idea of therapeutic approaches against extracellular citrullination that specifically inhibit PAD once outside the cell to keep the physiological effector functions of intracellular PAD and NETs, fundamental in several biological process regulation and in infectious diseases while avoiding the downstream proinflammatory effects due to hypercitrullination (57).